1,2-dipalmitoylphosphatidylglycerol has been researched along with Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eibl, H; Hahn, J; Hossann, M; Issels, RD; Lechner, K; Limmer, S; Lindner, LH; Schmidt, R; Wachholz, K; Zengerle, A | 1 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylglycerol and Sarcoma
| Article | Year |
|---|---|
Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Delayed-Action Preparations; Deoxycytidine; Doxorubicin; Gemcitabine; Half-Life; Hyperthermia, Induced; Liposomes; Male; Phosphatidylglycerols; Rats; Sarcoma | 2014 |